Table 1.

Clinical data of patients with giant cell myocarditis

	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6
Sex	F	F	F	F	M	M
Age	56	21	46	51	47	52
Presentation	HF	Arrhythmia	Arrhythmia	HF	HF	HF
ECG findings	N/A	VT	VT	AV block	AV block	N/A
Blood pressure (mmHg)	101/60	108/76	135/97	118/72	130/90	117/84
Heart rate (b.p.m.)	66	91	69	77	82	87
NYHA class	III	IV	III	IV	III	III
CRP (mg/L)	119	21	99	23	13	93
IL‐6 (pg/mL)	N/A	14	4.07	N/A	N/A	N/A
PCT (ng/mL)	3.12	0.04	0.02	0.15	N/A	N/A
cTNI (ng/mL)	29.15	0.41	1.09	53.15	0.04	96
NT‐proBNP (pg/mL)	27 917	11 399	3939	1806	4931	2250
Leucocytes (109/L)	25.73	13.55	7.62	7.17	8.09	7.37
Co‐morbidities	Infection, SIRS, anaemia	Orbital inflammatory pseudotumour, reflux esophagitis, pneumonia	Reflux esophagitis, diabetes, hypertension	Hypertension, hyperlipidaemia	N/A	N/A
Immunosuppressive therapy	Methylprednisolone, dexamethasone	Prednisone, cyclosporine	Methylprednisolone, mycophenolate mofetil, cyclosporine	Prednisone, mycophenolate mofetil, cyclosporine	Azathioprine, prednisone, cyclosporine	Prednisone, mycophenolate mofetil, cyclosporine
MCS	ECMO, IABP	IABP	N/A	N/A	N/A	N/A
Outcome	Cardiac death	Survival with IS	ICD discharge	HT	HT	HT

AV, atrioventricular; CRP, C‐reactive protein; cTNI, cardiac troponin I; ECG, electrocardiogram; ECMO, extracorporeal membrane oxygenation; F, female; HF, heart failure; HT, heart transplantation; IABP, intra‐aortic balloon pump; ICD, implantable cardioverter defibrillation; IL‐6, interleukin‐6; IS, immunosuppressant; M, male; MCS, mechanical circulatory support; N/A, not applicable; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; NYHA, New York Heart Association; PCT, procalcitonin; SIRS, system inflammatory reaction syndrome; VT, ventricular tachycardia.